Proscia

About:

Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.

Website: https://www.proscia.com

Twitter/X: Proscia

Top Investors: Scale Venture Partners, Fusion Fund, Hitachi Ventures, Alpha Intelligence Capital, Flybridge

Description:

Proscia develops a digital pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes. Its platform utilizes computing technologies that unlock hidden data not visible to the human eye and turns that data into valuable insights to help physicians accelerate the development of life-saving advances.

Total Funding Amount:

$80.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2014-07-01

Contact Email:

info(AT)proscia.com

Founders:

Coleman Stavish, David West, Nathan Buchbinder

Number of Employees:

101-250

Last Funding Date:

2024-01-11

IPO Status:

Private

© 2024 MyAiNote.com